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Following optimization of extraction, separation and analytical conditions, a rapid, sensitive and simple 
reverse-phase high performance liquid chromatography-photo diode array (HPLC-PDA) method 
has been developed for the identification and quantification of wedelolactone in different extracts of 
Eclipta alba. The separation of wedelolactone was achieved on a C18 column using the solvent system 
consisting of a mixture of methanol: water: acetic acid (95: 5: 0.04) as a mobile phase in isocratic elution 
mode followed by photo diode array detection at 352 nm. The developed method was validated as per 
the guidelines of the International Conference on Harmonization (ICH). Calibration curve presented 
good linear regression (r2>0.998) within the test range and the maximum relative standard deviation 
(RSD, %) values for intra-day assay were found to be 0.15, 1.30 and 1.1 for low (5 µg/mL), medium  
(20 µg/mL) and high (80 µg/mL) concentrations of wedelolactone. For inter-day assay the maximum 
RSD (%) values were found to be 2.83, 1.51 and 2.06 for low, medium and high concentrations, 
respectively. Limit of detection (LOD) and limit of quantification (LOQ) were calculated to be 2 and 
5 μg/mL respectively. Analytical recovery of wedelolactone was greater than 95%. Wedelolactone in 
different extracts of Eclipta alba was identified and quantified using the developed HPLC method. The 
validated HPLC method allowed precise quantitative analysis of wedelolactone in Eclipta. alba extracts.
Uniterms: High performance liquid chromatography/quantitative analysis. High performance liquid 
chromatography/photo diode array/method validation. Eclipta alba/extracts/analysis. Wedelolactone/
quantification.
Desenvolveu-se método rápido, sensível e simples de Cromatografia Líquida de Alta Eficiência em fase 
reversa, utilizando-se arranjo de fotodiodo (HPLC-PDA), visando à separação, extração e às condições 
analíticas para a identificação e quantificação de wedelolactona em diferentes extratos de Eclipta 
alba. A separação de wedelolactona foi efetuada por meio de uma coluna C18, utilizando mistura de 
metanol:água:ácido acético (95:5:0.04) como fase móvel, em sistema de eluição isocrática, seguida de 
detecção por arranjo de fotodiodo a 352 nm. O método desenvolvido foi validado de acordo com as 
diretrizes da Conferência Internacional de Harmonização (ICH). As curvas de calibração apresentaram 
boa regressão linear (r2>0,998), dentro dos intervalos de teste, e os valores máximos de desvio padrão 
relativo (RSD,%) dos ensaios intra-dia foram 0,15, 1,30 e 1,1 para concentrações de wedelolactona 
baixa (5 mg/mL), média (20 mg/mL) e elevada (80 mg/mL) Para o ensaio inter-dia,os máximos de RSD 
(%) foram 2,83, 1,51 e 2,06 para as concentrações baixa, média e alta, respectivamente. O Limite de 
Detecção (LD) e o Limite de Quantificação (LOQ) foram de 2 e 5 mg/mL, respectivamente. A recuperação 
analítica de wedelolactona foi maior do que 95%. A wedelolactona em diferentes extratos de Eclipta 
alba foi identificada e quantificada pelo método de HPLC desenvolvido. O método de HPLC validado 
permitiu a análise quantitativa precisa de wedelolactona em extratos de Eclipta alba.
Unitermos: Cromatografia líquida de alta eficiência/análise quantitativa. Cromatografia líquida de 
alta eficiência/em fase reversa/validação de método. Eclipta alba/extratos/análise. Wedelolactona/
quantificação.
S. Kumar, T. Dhanani58
INTRODUCTION
Eclipta alba (L.) Hassk. Syn. E. erecta L. “bhrin-
garaja” belonging to the family of Asteraceae, is a small, 
branched annual herb with white flower heads. The plant 
grows abundantly as weed in cool, moist places throughout 
India (Chopra et al., 1956; Rastogi, Mehrotra, 1991). In 
Ayurvedic system of medicine, this plant is described as 
the best drug for treatment of liver cirrhosis and infective 
hepatitis. The plant juice is applied locally to treat finger 
decay caused due to infection during rainy season and 
extract is given in chronic fever. Leaf juice with buttermilk 
is used as antidote for snakebite. Shoot juice of E. alba 
mixed in equal amount with shoot juice of Oxalis cornicu-
lata Linn. is used as drops in injured eyes. The decoction 
of the plant is given for headache. The herb is reported to 
exhibit immuno-stimulatory activity and aqueous extract 
possessed myocardial depressant and hypotensive effect, 
unrelated to cholinergic acid and histaminergic effect in 
experimental animals. Coumestans, polypeptides, poly-
acetylenes, thiophene derivatives, steroids, triterpenes, and 
flavonoids have been reported as the main constituents of 
E. alba (Sarg et al., 1981). β-Amyrin, wedelolactone and 
luetolin 7-O-glucoside have been isolated from the aerial 
parts of the plant (Sikoria et al., 1982). Hentricontanol, 
14-heptacosanol and stigmasterol have been reported from 
the roots of the plant (Singh et al., 1985). The coumestan, 
wedelolactone (Figure 1), is the bioactive principle of 
aerial parts of E. alba. Various biological activities such as 
hepatoprotective, antiplasmodial, sedative, anxiolytic, noo-
tropic and anti-stress have been reported for wedelolactone 
(Saxena et al., 1993; Simonsen et al., 2001; Thakur et al., 
2005). Wedelolactone exhibited activity as an antidote to 
snake venom (Bothrops jararaca). Albino mice (20 g aver-
age weight) were given a dose of 100 mg/kg of wedelolac-
tone isolated from Eclipta prostrata by oral administration 
of one hour prior to envenomation. Ninety percent albino 
mice survived after six hours of envenomation and after 24 
and 48 hours of being envenomed, forty percent survival 
was reported (Pereira et al., 1994). Although, chemical 
synthesis of wedelolactone has been reported by several 
groups (Chang et al., 2008), there are only few high per-
formance liquid chromatography method for identification 
and quantification for wedelolactone in extracts of E. alba. 
Furthermore, reported methods are time consuming with 
analysis time varying from 30-40 minutes (Murali et al., 
2002; Wagner et al., 1986) and not validated as per ICH 
guidelines. Therefore, present investigation was undertaken 
to develop a rapid, sensitive high performance liquid chro-
matography method for identification and quantification of 
wedelolactone in extracts of E. alba.
MATERIAL AND METHODS
Material and Chemicals
Whole plant of E. alba was collected from the ex-
perimental field of Directorate of Medicinal and Aromatic 
Plants Research, Boriavi, Anand in 2010. HPLC grade 
acetonitrile, methanol and water (Merck, Mumbai, In-
dia) were used. Standard wedelolactone purchased from 
Sigma-Aldrich was used for identification of peak and 
preparation of calibration curve.
Instrumentation
The HPLC system consisted of a Waters 600 E pump 
(Milford, MA, USA) equipped with quaternary solvent 
delivery system, 2996 photodiode array detector. Instru-
ment control and data processing were performed using 
Empower software. The chromatographic separation was 
achieved using a SunFireTM C18 column (4.6 × 150 mm 
packed with 5 µm particle size; Waters, USA) at 25 oC.
Methodology
Preparation of extract samples
Whole plant of E. alba was dried in shade. Dried plant 
was finely powdered using an electric grinder and used for 
preparation of the extract. Powdered sample was extracted 
with methanol (250 mL X 6) for 24 h at 25 ºC. The methanol 
extracts thus obtained were pooled together and concen-
trated under reduced pressure to obtain methanolic extract. 
Methanolic extract was suspended in water (200 mL) 
and fractionated with hexane (100 mL × 6), chloroform 
(100 mL × 6), ethyl acetate (100 mL × 6) and n-butanol 
(100 mL × 6) successively. The hexane extracts obtained 
were combined together, dried over anhydrous sodium sul-
fate and concentrated under reduced pressure to a residue 
of hexane extract. Similar processing of chloroform, ethyl 
acetate and n-butanol extracts provided their concentrated 
extracts, respectively. These concentrated extracts were 
further vacuum dried to remove traces of solvents.
FIGURE 1 - Chemical structure of wedelolactone.
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Preparation of standard solution
The standard stock solution (1000 µg/mL) of we-
delolactone was prepared in HPLC grade methanol and 
stored at 4 ºC. Working solutions of lower concentrations 
were prepared by appropriate dilution of the stock solution 
in methanol. Stock solutions of different extracts of E. alba 
were prepared by dissolving 1 mg of the extract in 1 mL 
methanol and filtered through a 0.45 µm membrane filter.
HPLC analysis
To obtain HPLC chromatogram with good resolu-
tion and short analysis time per run, the chromatographic 
conditions were optimized, including the mobile phase 
and flow rate. The mobile phase was filtered through 0.45 
µm membrane filter in solvent filtration apparatus (Mil-
lipore, USA). The solvents were degassed using vacuum 
before use. Several reverse phase HPLC columns were 
explored for the optimal separation including Symmetry 
C18 (250 × 4.6 mm, 5 µm), X Terra (250 × 4.6 mm, 5 µm) 
and SunFire (4.6 × 150 mm, 5 µm) (Waters, Milford, MA, 
USA) and Lichro CARTR 250-4 C18 column (250 × 4.6 mm 
packed with 5µm particle size) (Merck, Germany). How-
ever, the best chromatographic separation was achieved 
using SunfireTM C18 column at 25 oC. Both acetonitrile-
water and water-methanol were tested as the mobile phase 
system under isocratic as well as gradient elution mode. 
However, methanol-water-acetic acid (95: 5: 0.04) as mo-
bile phase in isocratic elution with a flow rate 0.6 mL/min 
provided better peak shape and resolution. Analysis was 
performed with a total runtime of 10 min. Detector wave-
length was 352 nm and the injection volume was 10 µL. At 
 FIGURE 2 - HPLC-PDA chromatogram of standard wedelolactone (concentration=20 ppm) at 352 nm, mobile phase consisting 
of methanol: water: acetic acid (95: 5.0: 0.04) on Sunfire (4.6 × 150 mm, 5 µm) column at a flow rate of 0.6 mL/min.
this wavelength, wedelolactone has adequate absorption 
according to its three-dimensional ultraviolet absorption 
spectra. Mean retention time was 2.9 min (Table I). A 
chromatogram of standard wedelolactone has been shown 
in Figure 2.
RESULTS AND DISSCUSSION
Validation of the HPLC method
Linearity
As the linear range of analytical method is known 
to be limited, linearity of the calibration curve prepared 
and its working range was determined. Determination of 
linearity was based on detector response of the different 
concentrations of standard used for calibration curve. 
Regression analysis was used to access the linearity of the 
developed HPLC method using the equation, y = bx + c , 
where, x correspond to the concentration of the standard 
solution (µg/mL), y is the peak area, b is slope of the line, 
TABLE I - Method validation data for determination of 
wedelolactone
Data Value
Mean retention time 2.89 min (RSD 0.7%)
Linear range 5-100 µg/mL
Regression coefficient 0.998
Limit of detection (LOD) 2 µg/mL
Limit of quantification (LOQ) 5 µg/mL
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and c is intercept of the straight line with y axis. In the 
present study, linearity was studied in the concentration 
range of 5-100 µg/mL of the standard solution of wedelo-
lactone (Table I). The calibration curve was linear in this 
concentration range and showed good linear regression (Y 
= 86558 x - 125096, r2 = 0.998).
Limit of detection (LOD) and limit of quantification 
(LOQ)
Lowest concentration of analyte detectable and 
quantifiable with a stated degree of reliability is one of 
the many important parameters of any analytical method. 
Limit of detection (LOD), signal to noise ratio (S/N) = 3 
or above is the lowest amount of analyte in a sample that 
can be detected but not necessarily quantified. Limit of 
quantification (LOQ) is defined as the lowest concentra-
tion, which can be reproducibly quantified above baseline 
level, typically for LOQ, S/N = 10 or above. The LOD 
and LOQ for the present HPLC method developed were 
measured as per guidelines described by the International 
Conference on Harmonization (ICH, 1996). LOD and 
LOQ as determined were found to be 2 and 5 µg/mL re-
spectively (Table I).
Precision
Intraday precision (repeatability) was evaluated for 
three concentrations (low, medium and high) of standard 
with duplicate injections during the same day, under the 
same experimental conditions. Inter day precision was also 
measured for the same three concentrations during three 
different days. Intraday precision of the analyte was in the 
range of 0.15-1.1 % and the inter day precision varied from 
2.06-2.83% (Table II). The specificity of the method was 
examined by analyzing blank sample and blank sample 
spiked with a known concentration of wedelolactone. 
No interference in the retention time of the analyte was 
observed.
Accuracy
The accuracy of an analytical method is the close-
ness of test results obtained by that method to the true 
value and was determined based on the recovery of known 
amounts of analyte. Analytical recovery was performed by 
analyzing analyte by spiking 60 µg/mL of the standards in 
blank extract (aqueous extract) for six different days. The 
recovery ranged from 95.80 to 101.76%.
Application to the identification and 
quantification of wedelolactone in different 
extracts of E. Alba
For locating the best fraction enriched with we-
delolactone, methanol extract was further fractionated 
using solvents of varying polarity to get hexane, chlo-
roform, ethyl acetate and n-butanol extracts. Thereafter, 
the developed HPLC method was applied to determine 
the concentration of wedelolactone in different extracts. 
Peak of wedelolactone in different extracts was identified 
on the basis of retention time of standard wedelolactone 
(Figure 3-7). From the chromatograms of different ex-
tracts, it was concluded that as the polarity of solvent used 
for liquid-liquid fractionation increased the extracts were 
purified and the area of additional peaks decreased. Many 
additional peaks were recorded in HPLC chromatogram of 
hexane extract, however, no additional peak was observed 
in n-butanol extract. Quantity of wedelolactone in different 
extracts was calculated from the peak area of HPLC chro-
matograms of the extracts and its content in different ex-
tracts has been summarized in Table III. This information 
could be utilized for development of up-scaling process.
Solvent and method used for extraction affects the 
functional efficacy of medicinal plants extracts. Kulkarni 
et al. (2011), reported extraction of wedelolactone from 
E. alba using six different methods of extraction and its 
estimation by HPTLC. The highest percentage of we-
delolactone was found in extract prepared by Soxhlet 
extraction and lowest in case of Supercritical fluid extrac-
tion; the yield difference was attributed to polar nature 
of wedelolactone. It has been reported that partitioning 
with polar solvents led to enrichment of wedelolactone 
TABLE II - Accuracy and precision (R.S.D.) of the method 
developed at three different concentrations
Analyte
Concentration (µg /mL) 
RSD (%)
 Intra-day Inter-day
5 (Low) .15 2.83
Wedelolactone 20 (Medium) 1.31 1.51
80 (High) 1.1 2.06
TABLE III - Wedelolactone content (mean ± S.D) in different 
extracts of E. alba
Extract Wedelolactone (%)
Methanol 6.62+ 0.93
Hexane 0.80+ 0.03
Chloroform 0.94+0.12
Ethyl acetate 8.24+ 0.70
n-Butanol 11.81+0.64
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FIGURE 3 - HPLC-PDA chromatogram of methanol extract of E. alba.
FIGURE 4 - HPLC-PDA chromatogram of hexane extract of E. alba.
FIGURE 5 - HPLC-PDA chromatogram of chloroform extract of E. alba.
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FIGURE 6 - HPLC-PDA chromatogram of ethyl acetate extract of E. alba.
FIGURE 7 - HPLC-PDA chromatogram of n-butanol extract of E. alba.
in extract. Wagner et al. (1986) reported 1.6% and 15.9% 
wedelolactone in methanol and ethyl acetate extracts of E. 
alba respectively. In the present study, the butanol fraction 
has highest content of wedelolactone; we speculate that 
this fraction of E. alba may provide maximum bioactivity. 
Similar results have been reported by Kim et al., (2008). 
The earlier reported HPLC methods (Murali et al., 2002; 
Wagner et al., 1986) were not validated; we validated the 
developed method as per ICH guidelines. Further, use of 
acetic acid in place of phosphoric acid will enhance the 
longevity of HPLC column.
CONCLUSION
The validated HPLC method allows a simple, ac-
curate and precise quantitative analysis of a biologically 
important molecule wedelolactone from E. Alba. Pres-
ence or absence of wedelolactone in different extracts 
of E. Alba, related species and commercial formulations 
can be confirmed by comparing their retention times (tR) 
using developed method. Moreover, maximum wedelo-
lactone content was found in n-butanol extract followed 
by ethyl acetate extract, thus it appears that n-butanol or 
ethyl acetate would be a suitable solvent for partitioning 
of the methanol extract for isolation of wedelolactone 
from E. alba.
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